BMC Complementary and Alternative Medicine · 2019 · 35 citations · 20 references
MedicineMedicinal ChemistryPharmacologyBiochemical PharmacologyCancer PharmacologyStructure-activity RelationshipsMedicinal Plant KnowledgeMedicinal PlantsMetabolite ExtractionNatural Product Drug DiscoveryOncology PharmacologyStructure-activity Relationship AnalysisBioactive Plant CompoundsBioactivityBioassay-guided FractionationCell Cycle InhibitionMedicinal HerbsMedicinal Plant ResourcesPharmacological ScreeningPlant Alkaloids
BACKGROUND: The plant Holarrhena floribunda (H. floribunda; G. Don) is indigenous to sub-Saharan Africa and is traditionally used to treat several ailments. The present study was carried out to isolate and characterize bioactive compounds with anti-proliferative activity present in H. floribunda extracts. METHODS: Compounds were isolated from H. floribunda using the bioassay-guided fractionation technique of repeated column chromatography and the step-wise application of the MTT reduction assay to assess antiproliferative bioactivity. The structures of the compounds were identified mainly using NMR. The effects of the isolated compounds on the viability, cell cycle and proliferation of human cancer cell lines (MCF-7, HeLa and HT-29) as well as the non-cancerous human fibroblast cell line (KMST-6) were investigated. RESULTS: /M phases in the cancer cell lines with significant reduction in DNA synthesis. The results obtained show that the cancer cells (MCF-7, HeLa and HT-29) used in this study were more sensitive to the isolated compounds compared to the noncancerous fibroblast cells (KMST-6). CONCLUSION: The ability of the isolated compounds to cause cell cycle arrest and reduce DNA synthesis raises hopes for their possible development and use as potent anticancer drugs. However, more mechanistic studies need to be done for complete validation of the efficacy of the two compounds.
20
Promotion of microtubule assembly in vitro by taxol
Peter B. Schiff, Jane Fant, Susan Band Horwitz · Nature · 1979 · 3.6K citations
Arjan A. van de Loosdrecht, R.H.J. Beelen, GJ Ossenkoppele et al. · Journal of Immunological Methods · 1994 · 802 citations · Full text
Medicine, Hematology, Oncology +7
Studies on succinate-tetrazolium reductase systems
T. F. Slater, B. C. Sawyer, Ursula Sträuli · Biochimica et Biophysica Acta · 1963 · 768 citations
Soluble Extract from Moringa oleifera Leaves with a New Anticancer Activity
Il Lae Jung · PLoS ONE · 2014 · 273 citations · Full text
Medicine, Oncology, Pharmacology +16
Tubulin and microtubules as targets for anticancer drugs.
John A. Hadfield, Sylvie Ducki, Nicholas Hirst et al. · PubMed · 2003 · 247 citations
Medicine, Oncology, Pharmacology +12